Status of LLA treatment among patients with documented dyslipidemia, according to Framingham risk score
| FRAMINGHAM RISK SCORE | TREATED, n (%) | UNTREATED, n (%) |
|---|---|---|
| Low | 37,781 (22.81) | 127,863 (77.19) |
| Intermediate | 36,467 (48.73) | 38,367 (51.27) |
| High | 20,576 (65.04) | 11,058 (34.96) |
| Missing data | 51,448 (73.79) | 18,276 (26.21) |
LLA—lipid-lowering agent.